IL38023A - Isoindoline derivatives and process for their preparation - Google Patents
Isoindoline derivatives and process for their preparationInfo
- Publication number
- IL38023A IL38023A IL38023A IL3802371A IL38023A IL 38023 A IL38023 A IL 38023A IL 38023 A IL38023 A IL 38023A IL 3802371 A IL3802371 A IL 3802371A IL 38023 A IL38023 A IL 38023A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- formula
- general formula
- compounds
- reacting
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 23
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical class C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 79
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 claims description 6
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- 239000000203 mixture Substances 0.000 description 21
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 16
- 238000010992 reflux Methods 0.000 description 15
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- 238000002425 crystallisation Methods 0.000 description 10
- 230000008025 crystallization Effects 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 4
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- -1 ethanol ester Chemical class 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- QOPBEBWGSGFROG-UHFFFAOYSA-N 2-(1h-indol-2-yl)acetic acid Chemical compound C1=CC=C2NC(CC(=O)O)=CC2=C1 QOPBEBWGSGFROG-UHFFFAOYSA-N 0.000 description 1
- RLQZIECDMISZHS-UHFFFAOYSA-N 2-phenylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C=CC(=O)C(C=2C=CC=CC=2)=C1 RLQZIECDMISZHS-UHFFFAOYSA-N 0.000 description 1
- 241001535291 Analges Species 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 125000005543 phthalimide group Chemical class 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
ISOINDOLINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION and and to a process for their In recent years the search for with c and activity shifted fields of cortisone congeners endowed with hormonal end morphine narcotics to other classes of While products with undeniable pharmacological activity have been the problem is far from completely because of these products are quite toxic and poorly causing as among other gastrointestinal they cause harmful secondary Certain isoindoline have been found to be characterized by a negligible toxicity and to be tolerated very since they cause no secondary The object of this have the following general wherein R is a member selected from the group consisting of hydrogen and lower alkyl of 1 to 4 carbon and is a member selected from the group consisting of lower alkyl of 1 to 4 carbon atoms and a group of general formula n is 1 or 2 and and are independently selected from the group of hydrogen and lower alkyl of 1 to 4 carbon The scope of the invention also comprises the salts of the compounds of general formula wherein is with physiologically genera with physiologically acceptable organic or inorganic Tho compounds general formula may be prepared by the following reacting as prepared by bromination commercially available with at a temperature of about with a compound of general formula wherein is or cyano group and is as defined as prepared by reduction with Fe and NH CI or by catalytic hydrogenation of the corresponding nitroderivative obtained in its turn by nitration of the compound of formula page with methods described in literature for analogous at a temperature of about 75 to about in polar such as methanol or the to form a compound of general formula wherein R and X are as defined which is subsequently r with suitable such for or the or with suitable such for of about 75 to about to give compounds of general formula is and if esterifying at a temperature of about 60 to about the compounds of general formula wherein is thus the according to the usual methods organic or reacting commercially available phthalide with a compound of general formula at a temperature of about about obtaining a compound of formula wherein X and are as defined which is subsequently with suitable such for K CO or the or with suitable such for at a temperature of about 75 about to give compounds of general formula wherein is and if esterifying at a temperature of about 60 to about the compounds of general formula wherein is thus le oho according to the usual methods of organic or reacting tiophthalide as prepared according to the method of Prey and 1 disclosure of which is hereby incorporated by with a compound of formula at a temperature of about to about preferably in sealed so obtaining a compound of formula which is subsequently to give compounds of general formula wherein is if are esterified as described in process or with a compound of formula at a temperature of about 50 to about in polar such for dimethyl and the so obtaining a compound of formula which is subsequently to give compounds of general formula wherein is if are esterified as described in process or reacting commercially available phthalic anhydride with a compound of formula at a temperature bout 60 to about so obtaining a compound of formula wherein X and R are as defined which is subsequently reduced with a suitable reducing such for Zn and and the at a temperature of about 60 to about to give a compound of formula which is sub sequently to give compounds of general formula wherein is if are esterified as described in process or reacting commercially available compounds of general formula wherein the groups are both both methyl or both ethyl with a compound of formula at a temperature of about 80 to about in the presence or absence of a so obtaining a compound of formula wherein X and R are as defined which is subsequently reduced to give a compound of formula which is then saponified to give compounds of general formula wherein is if are esterified as described in process Prom the above reaction sequences it appears evident that if compounds of general formula wherein is an ethyl are desired to be processes and may be the case when the compounds of general formula wherein X is the carbethoxy As hereabove esterification of the compounds of general formula wherein is hydrogen to if compounds of general formula wherein is different from is performed according methods of organic as is known to those skilled in the For the esters of the compound of general formula wherein is may be prepared by treatment of said compounds with SOClg at a temperature of about βθ to about in the presence or absence of and subsequently by reacting the acid chloride so at room temperature in apolar such for and the The compounds of general formula wherein is may alsc be if into their salts with physiologically ceptable the according to the usual methods of organic as is known to those skilled in the For the salts of the compounds of general formula wherein is with may be obtained by at room temperature co if into their salts with physiologically acceptable organic or inorganic according to the usual methods of organic as is known to those skilled in the The object of the present possess a good analge and as shown by the data reported in the table herebelow where hen lbutazone i A L Analgesic activity was assessed by means of phenylquinone test in mice according to Siegmund et 1 activity was assessed by means of carrageenin induced edema test in rats according to Winter et 544 and Table 2 shows the activity of in comparison with acid scribed in Eelgian Patent Table 2 In table 2 activity was determined employing both the as previously and granuloma pouch technique Stevenson 153 205 The potency ratios were estimated following the parallel line biological assay method Statistical Method in Biological Assay Griffin London The pharmacological data hereabove reported have been confirmed by clinical trials performed on The compounds of the present invention are preferably administered but they can also be administered by parentheral or topical The pharmaceutical compositions containing the compounds of this vention can be therefore either Examples of the substances which can serve as pharmacological carriers or diluents for the pharmaceutical compositions of the compounds of the invention are magnesium as well as other compatible substances used in pharmaceutical formulations The following examples but do not the scope of the present Example 1 A mixture of ethyl and 5 2 in EtOH 9 is heated with a reflux condenser for added char and filtered during The filtrate is concentrated to about one third and then poured in ethyl ether The precipitate is tered and washed again with ethyl ether 100 to obtain HBr In the same and by reacting with the proper amino the following compounds are 1 Example 2 dissolved in EtOH is added to dissolved in water The mixture of the reagents is heated with a reflux condenser under mixing for 8 hours thus obtaining a complete Ethyl alcohol is evaporated under the solved residue filtered and the filtrate is acidified with HC1 60 The precipitate thus formed is washed with water with HC1 and again with water to after crystallizat ion from EtOH doline yield In the same and by employing the compounds prepared according to Example the following compounds are Example 3 A mixture of and acid in EtOH is heated with a reflux condenser for 6 evaporated to little volume under vacuum and then poured in ethyl ether 400 The separated solid is crystallized from EtOH ethyl ether to obtain HBr yield This product dissolved in EtOH 9 is added to dissolved in water The mixture of the reagents is refluxed for 12 hours to obtain a complete Ethyl alcohol is evaporated under the undissolved residue filtered and the trate is acidified with HC1 The precipitate thus formed is washed with water with HC1 and again with water to after crystallization from EtOH 7 yield In the same and by reacting with the proper amino the following compounds are 1 arboxy me hylj C Example 4 Phthalide and ethyl are heated to for 4 hours in a sealed then treated with water acidified with HC1 and extracted with ethyl acetate The organic layer is washed with water dried and evaporated to dryness in r The oily residue is crystallized from ligroin to obtain yield In the same and by reacting phthalide with the proper amino esters the following compounds are thy l 1 iso indol ine Example Tiophthalide and ethyl are heated to for hours in a sealed then treated with water acidified with HC1 and extracted with ethyl acetate The ganic layer is washed with dried and evaporated to ness in The residue is crystallized from ligroin to obtain 1 isoindoline yield In the same and by reacting tiophthalide with the proper amino the following compounds are Example 6 To a solution of phthalic aldehyde suspended in dimethylforraamide 200 heated to ethyl 86 dissolved in dimethylformamide is added in the course of an The mixture is stirred again for 2 hours at the solvent is evaporated under The oily residue is dissolved in ethyl acetate 80 washed with HCl and with water 30 The organic layer is evaporated to dryness and the residue is cristallized ligroin to obtain 5 25 yield In the same and by reacting phthalic aldehyde with the proper amino the following compounds are Example 7 A mixture of phthalic anhydride 1 and ethyl 1 in acid 70 is heated with a reflux condenser for 4 then cooled at about and diluted with water 50 An oily thus solidifies after is then cooled at filtered and washed with water 40 to after crystallization from EtOH 30 yield 1 In the same and by reacting phthalic anhydride with the proper amino the following compounds are 1 Example 8 A mixture of phthalic acid and ethyl e is heated in an oil bath at for and a then to aftor crystallization from EtOK yield In the same and by reacting phthalic acid with the proper amino the following compounds are iinide C Example 9 Ethyl ester of phthalic acid and ethyl suspended in anhydrous heated with a reflux condenser for 4 The mixture is evaporated to under the residue is redissolved in ethyl acetate then washed with HC1 with water dried and evaporated to dryness under to after crystallization from EtOH 9 yield In the same and by reacting ethyl ester of phthalic acid with the proper amino the following compounds are imi de Example 10 To a solution of suspended in acetic acid Zn in powder added under The mixture is with a reflux condenser for 4 and the residue is then washed with warm acetic acid The filtrate is evaporated to dryness under the residue is redissolved in water and neutralized with sodium bonate to give pH The thus is filtered to after crystallization from yield In the same and starting phthalimides prepared according to Examples 8 and following compounds are 1 carbethoxyme ndol ine thy l indol Example A mixture of 1 indoline and in EtOH and water is heated with a reflux condenser for 8 hours to obtain a complete Ethyl is evaporated under the aqueous solution is acidified with HC1 and thus is washed with water to after crystallization from EtOH yield In the same and starting from the derivatives prepared according to Examples and the following compounds are carboxymethyl indol Example A mixture of and in EtOH 99t9 is heated with a reflux condenser for 6 hours and evaporated to obtain o yield In the same and by reacting with the proper the following compounds are HBr HBr HBr HBr Example To HBr dissolved in EtOH dissolved in water 20 is The mixture is heated a reflux condenser for 10 hours and The residue is washed with water to after crystallization EtOH 99 yield In the same and starting from the derivatives prepared according to Example 12 the following compounds are Example 14 A mixture of phthalide and is heated to for 4 hours in a sealed treated with water 100 acidified with HCl and extracted with ethyl acetate 200 The organic layer is washed with water 80 dried and evaporated to dryness under The residue is crystallized from EtOH 99 9 to obtain 57 yield In the same and by reacting phthalide with the proper amino Example A mixture of tiophthalide and is to for 4 hours in a sealed redissolved in water acidified with HCl and extracted with ethyl acetate The organic layer is washed with water dried and evaporated to dryness under The residue is crystallized from EtOH obtain indoline yield In the same and by reacting tiophthalide with the proper amino the following compounds are 1 Example To a solution of phthalic aldehyde suspended in dimethylformamide heated to tonitrile dissolved in dimethylformamide OO is added in the course of an The mixture is stirred again for 4 hours at the solvent is evaporated under The oi residue is dissolved in ethyl acetate washed with HCl 8 ml then with water The organic layer is dried and evaporated to dryness under The residue crystallized from EtOH obtain yield 1 In the same and by reacting phthalic aldehyde with the proper amino the following compounds are ne Example 1 7 A mixture of phthalic anhydride 12 and in glacial acetic acid 0 is heated with a reflux condenser for 4 hours thus taining a complete The mixture is then and the solid separated is washed with water and dried to obtain 1 yield In the same and by reacting phthalic anhydride with the proper amino the following compounds are Example A mixture of phthalic acid 32 and is heated in an oil bath to for an hour and a then redissolved with water and the thus is filtered to obtain yield 21 In the same and by reacting phthalic acid with the proper amino the following compounds are hthalimide Example 19 A of ethyl ester of phthalic acid and o suspended in anhydrous dimethylforrnamide 100 is heated with a reflux condenser for 4 evaporated to dryness under the residue is then redissolved with ethyl acetate washed with HCl then with water subsequently dried and evaporated to dryness under The residue is crystallized from EtOH to obtain 3 yield 75 21 In the same and by reacting ethyl ester of phthalic acid with the proper amino the following compounds are Example 20 To a suspension of 76 in glacial acetic acid 50 heated to Zn in powder is added The mixture is then heated with a reflux condenser for 14 The inorganic layer is the filtrate is and the solid thus is treated with then with and filtered The residue is crystallized from EtOH 9 obtain 1 yield In the same and starting from the derivatives prepared according to Example 1 and the following compounds are A suspension of indoline in H SO and water is heated with a reflux condenser 16 then poured into cold water 100 The solid separated is then treated with NaOH The insoluble residue is the filtrate is acidified with HC1 30 the solid is filtered and crystallized from EtOH to obtain 39 yield 85 21 In same and starting from the derivatives prepared according to Example 14 15 and the following compounds are Example 22 A solution of and concentrated sulfuric acid in anhydrous methyl alcohol 18Ο is heated with a reflux condenser for 6 then cooled and and the precipitate is washed with 100 to after crystallization from methyl yield 6 In the same and by reacting methyl alcohol with the proper isoindoline the following compounds are Example A solution of 20 O S0C1 1 20 is heated with a reflux condenser for 3 the then distilled then anhydrous with petroleum a solid is which by crystallization from a mixture of benzene and petroleum ether gives the acid chloride of 15 yield This acid chloride 12 is now dissolved in anhydrous dioxane and this solution is added under effective to a solution 12 in anhydrous dioxane to produce a slightly exothermic The mixture is agitated 3 hours at room The precipitate thus formed is then and the filtrate is evaporated under vacuum to make oily This residue is dissolved in the chloroform solution is washed with 2 100 dried on anhydrous sodium sulfate and evaporated to dryness under The residue is then extracted with hot and subsequently cooled to obtain ethanol ester of indoline yield In the same and by reacting with the acid chlorides of the proper the following compounds are obtained ester ester of methylj ester of ester of methyl Example 24 1 is added to moles suspended in water The solution is then lyophilized to obtain salt of o In the same and by reacting with the proper the following compounds are salt of salt of salt of methylj salt of insufficientOCRQuality
Claims (1)
1. WHAT WE Isoindoline derivatives of the general formula a from the group consisting of and lower alkyl of 1 to carbon and member from group consisting of lower to 4 and a group of general formula wherein n 1 or 2 are from the group of hydro and lower alkyl of 1 to 4 and physiologically acceptable basic addition salts of the compounds ine A process for the preparation of isoindoline derivatives according to any one of the preceding the process reacting with a compound of general formula wherein X is wherein R and X are as which is subsequently suitable bases or with to e compounds of general formula wherein and if the of general formula where in is thus with reacting phthalide with a compound of formula compound of formula reacting phthalic anhydride with a compound formula so obtaining a compound of formula wherein X and are as defined which is reduced with a suitable reducing to give a compound of formula which is subsequently saponif compounds of general wherein is if are esterified as described in process or reacting compounds of general formula wherein the grou are both both or both ethyl with a compound of formula obtaining a compound of formula wherein X and R are as defined which is subsequently reduced to give a compound of formula which is then saponi ed to give compounds of general formula wherein is if are esterified as described in process if reacting the compounds of general formula wherein appropriate base a physiologically salt or reac the compounds of general formula wherein is the group with an appropriate acid to give a physiologically A process according to claim substantially as described A compound of general formula prepared by a process according to claim or A pharmaceutical composition comprising a compound of general insufficientOCRQuality
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT3133470 | 1970-11-05 | ||
| IT3151470 | 1970-11-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL38023A0 IL38023A0 (en) | 1971-12-29 |
| IL38023A true IL38023A (en) | 1974-12-31 |
Family
ID=26328923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL38023A IL38023A (en) | 1970-11-05 | 1971-10-27 | Isoindoline derivatives and process for their preparation |
Country Status (18)
| Country | Link |
|---|---|
| JP (6) | JPS5111627B1 (en) |
| AT (1) | AT313894B (en) |
| BE (1) | BE774985A (en) |
| CA (1) | CA978973A (en) |
| CH (4) | CH559175A5 (en) |
| DD (1) | DD95379A5 (en) |
| DK (1) | DK154761C (en) |
| ES (1) | ES396473A1 (en) |
| FI (1) | FI54294C (en) |
| FR (1) | FR2112480A1 (en) |
| HU (1) | HU164391B (en) |
| IE (1) | IE35767B1 (en) |
| IL (1) | IL38023A (en) |
| MY (1) | MY7400288A (en) |
| NL (1) | NL170283C (en) |
| NO (1) | NO135785C (en) |
| SE (1) | SE374917B (en) |
| YU (1) | YU34984B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2154525A1 (en) * | 1970-11-05 | 1972-06-15 | Carlo Erba S.P.A., Mailand (Italien) | Isoindoline derivatives and processes for their preparation |
| DE2755345A1 (en) * | 1977-04-05 | 1978-10-19 | Grelan Pharmaceutical Co | 2-OXO-PHENYLBUTTERIC ACID DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PREPARATIONS CONTAINING THESE COMPOUNDS |
| JPS53145735U (en) * | 1977-04-23 | 1978-11-16 | ||
| JPS545333U (en) * | 1977-06-15 | 1979-01-13 | ||
| JPS5416115U (en) * | 1977-07-01 | 1979-02-01 | ||
| JPS5424235U (en) * | 1977-07-20 | 1979-02-17 | ||
| US5480362A (en) * | 1992-09-03 | 1996-01-02 | Honda Giken Kogyo Kabushiki Kaisha | Double planetary carrier |
| CN1302881C (en) * | 2004-12-10 | 2007-03-07 | 华东理工大学 | Method and apparatus for preparing superfine powder by super high pressure supercritical fluid micro jetting technology |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2034240C2 (en) * | 1968-03-27 | 1982-12-02 | CIBA-GEIGY AG, 4002 Basel | Isoindoline derivatives, processes for the preparation of these compounds and their use |
| JPS5035076A (en) * | 1973-08-01 | 1975-04-03 |
-
1971
- 1971-10-22 FI FI2988/71A patent/FI54294C/en active
- 1971-10-25 IE IE1342/71A patent/IE35767B1/en unknown
- 1971-10-27 IL IL38023A patent/IL38023A/en unknown
- 1971-10-28 ES ES396473A patent/ES396473A1/en not_active Expired
- 1971-10-29 YU YU2756/71A patent/YU34984B/en unknown
- 1971-11-04 SE SE7114082A patent/SE374917B/xx unknown
- 1971-11-04 CA CA126,830A patent/CA978973A/en not_active Expired
- 1971-11-04 NO NO4082/71A patent/NO135785C/no unknown
- 1971-11-04 DD DD158754A patent/DD95379A5/xx unknown
- 1971-11-04 HU HUCA317A patent/HU164391B/hu unknown
- 1971-11-04 AT AT952271A patent/AT313894B/en not_active IP Right Cessation
- 1971-11-05 CH CH1247674A patent/CH559175A5/xx not_active IP Right Cessation
- 1971-11-05 JP JP46088188A patent/JPS5111627B1/ja active Pending
- 1971-11-05 DK DK541671A patent/DK154761C/en not_active IP Right Cessation
- 1971-11-05 NL NLAANVRAGE7115288,A patent/NL170283C/en not_active IP Right Cessation
- 1971-11-05 CH CH1247574A patent/CH559174A5/xx not_active IP Right Cessation
- 1971-11-05 BE BE774985A patent/BE774985A/en not_active IP Right Cessation
- 1971-11-05 CH CH1615771A patent/CH558353A/en not_active IP Right Cessation
- 1971-11-05 CH CH1247774A patent/CH559176A5/xx not_active IP Right Cessation
- 1971-11-05 FR FR7139823A patent/FR2112480A1/en active Granted
-
1974
- 1974-12-30 MY MY288/74A patent/MY7400288A/en unknown
-
1975
- 1975-10-24 JP JP50128260A patent/JPS5168563A/en active Granted
-
1976
- 1976-04-02 JP JP51037027A patent/JPS5231066A/en active Granted
- 1976-04-02 JP JP51037028A patent/JPS5217463A/en active Pending
- 1976-04-02 JP JP51037026A patent/JPS5231065A/en active Granted
-
1978
- 1978-09-14 JP JP53113483A patent/JPS6019748B2/en not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS582935B2 (en) | 5↓-Production method of aroylpyrrole derivative | |
| GB1566497A (en) | Chalcone derivatives | |
| JPH0742290B2 (en) | Method for aroylating 5-position of 1,2-dihydro-3H-pyrrolo [1,2-α] pyrrole-1-carboxylic acid ester | |
| FI72719C (en) | SYNTESFOERFARANDE FOER PIROXIKAM SAMT MELLANPRODUKT. | |
| EP0080229B1 (en) | Salicylic derivatives of n-acetylcysteine | |
| IL38023A (en) | Isoindoline derivatives and process for their preparation | |
| Turner | Synthesis of Carnosine and Related Peptides by the Phthaloyl Method1 | |
| US4118504A (en) | Isoindoline derivatives for treating pain | |
| JPS584785A (en) | Manufacture of isosorbide-2-nitrate | |
| Ho et al. | Inhibitors of Monoamine Oxidase III: 9-Substituted-β-Carbolines | |
| CH628014A5 (en) | Gamma-aryl-gamma-oxoisovaleric acids having antiphlogistic and antalgic properties | |
| DE1695702C3 (en) | Process for the preparation of 1-acyl-2-carboxy-3-indolylacetic acids | |
| JPS6031823B2 (en) | Method for producing carbazole derivatives | |
| US2705232A (en) | Ternorcholanylthiazoles | |
| US2926167A (en) | Process of esterifying ib-hydroxy | |
| US4339601A (en) | Terephthalic acid derivatives and process for preparing them | |
| NO743135L (en) | ||
| US4252979A (en) | Terephthalic acid derivatives | |
| US4298610A (en) | Ester derivatives of quinolopyran-4-one-2-carboxylic acids and antiallergic antasthmatics | |
| JPS5919545B2 (en) | New tricyclic cage-shaped amine compound | |
| US2874156A (en) | Substituted l | |
| CA1089855A (en) | Derivatives of pyrazolo [1,5-a] pyrido [2,3- d]-pyrimidin-9(4h)-one | |
| US4352935A (en) | Process for obtaining P-acetamido phenol α-methyl-4(2'thienyl-carbonyl) phenyl acetate | |
| US2776290A (en) | Hydroxy cevchoninates and carboxylic | |
| JP2831000B2 (en) | (2-aminobenzoyl) acetic acid ester derivative |